Gaps and barriers in the control of blood glucose in people with type 2 diabetes
Open Access
- 1 February 2017
- journal article
- review article
- Published by SAGE Publications in Diabetes and Vascular Disease Research
- Vol. 14 (3), 172-183
- https://doi.org/10.1177/1479164116679775
Abstract
Background: Glycaemic control is suboptimal in a large proportion of people with type 2 diabetes who are consequently at an increased and avoidable risk of potentially severe complications. We sought to explore attitudes and practices among healthcare professionals that may contribute to suboptimal glycaemic control through a review of recent relevant publications in the scientific literature. Methods: An electronic search of the PubMed database was performed to identify relevant publications from January 2011 to July 2015. The electronic search was complemented by a manual search of abstracts from key diabetes conferences in 2014/2015 available online. Results: Recently published data indicate that glycaemic control is suboptimal in a substantial proportion (typically 40%–60%) of people with diabetes. This is the case across geographic regions and in both low- and higher-income countries. Therapeutic inertia appears to be an important contributor to poor glycaemic control in up to half of people with type 2 diabetes. In particular, prescribers are often willing to tolerate extended periods of ‘mild’ hyperglycaemia as well as having low expectations for their patients. There are often delays of 3 years or longer in initiating or intensifying glucose-lowering therapy when needed. Conclusion: Many people with type 2 diabetes are failed by current management, with approximately half not achieving or maintaining appropriate target blood glucose levels, leaving these patients at increased and avoidable risk of serious complications. Review criteria: The methodology of this review article is detailed in the ‘Methods’ section.Keywords
Funding Information
- AstraZeneca (69680)
This publication has 62 references indexed in Scilit:
- Barriers to, and facilitators in, introducing integrated diabetes care in Ireland: a qualitative study of views in general practiceBMJ Open, 2013
- Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA studyClinical Endocrinology, 2013
- Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes MellitusDiabetes Therapy, 2012
- A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 DiabetesThe New England Journal of Medicine, 2012
- Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) Diabetes StudyQJM: An International Journal of Medicine, 2011
- Tailoring treatment to the individual in type 2 diabetes practical guidance from theGlobal Partnership for Effective Diabetes ManagementInternational Journal of Clinical Practice, 2010
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesThe New England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008